Fluoxetine and norfluoxetine are potent inhibitors of P450IID6‐the source of the sparteine/debrisoquine oxidation polymorphism [letter]

K. Brosen^*, E. Skjelbo

^*Kontaktforfatter

Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › peer review

Originalsprog	Engelsk
Tidsskrift	British Journal of Clinical Pharmacology
Vol/bind	32
Udgave nummer	1
Sider (fra-til)	136-137
Antal sider	2
ISSN	0306-5251
DOI	https://doi.org/10.1111/j.1365-2125.1991.tb05630.x
Status	Udgivet - jul. 1991

Dokumenter og links

@article{a696a9c79e2c47c0ab9caadddeb0b8ea,

title = "Fluoxetine and norfluoxetine are potent inhibitors of P450IID6‐the source of the sparteine/debrisoquine oxidation polymorphism [letter]",

author = "K. Brosen and E. Skjelbo",

year = "1991",

month = jul,

doi = "10.1111/j.1365-2125.1991.tb05630.x",

language = "English",

volume = "32",

pages = "136--137",

journal = "British Journal of Clinical Pharmacology",

issn = "0306-5251",

publisher = "Wiley",

number = "1",

}

TY - JOUR

T1 - Fluoxetine and norfluoxetine are potent inhibitors of P450IID6‐the source of the sparteine/debrisoquine oxidation polymorphism [letter]

AU - Brosen, K.

AU - Skjelbo, E.

PY - 1991/7

Y1 - 1991/7

U2 - 10.1111/j.1365-2125.1991.tb05630.x

DO - 10.1111/j.1365-2125.1991.tb05630.x

M3 - Comment/debate

C2 - 1888636

AN - SCOPUS:0025915325

SN - 0306-5251

VL - 32

SP - 136

EP - 137

JO - British Journal of Clinical Pharmacology

JF - British Journal of Clinical Pharmacology

IS - 1

ER -